Observational studyScientific reports2025
Impact of temporal tear meniscus height on the tear osmolarity measurements.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tear hyperosmolarity plays a crucial role in initiation of inflammatory response and damage to ocular surface epithelia. Accurate measurement of tear osmolarity is essential for dry eye. This prospective observational and experimental study was conducted in 182 eyes of 182 participants, including 115 subjects with dry eye (Sjögren syndrome aqueous-deficient dry eye [SS ADDE], non-SS ADDE, and evaporative DE [EDE]), 36 with conjunctivochalasis (CCh), and 31 normal controls (NC). The ocular surface disease index (OSDI), tear meniscus height (TMH), Schirmer I test, tear matrix metalloproteinase-9 (MMP-9), tear breakup time, and ocular staining score were assessed. Tear osmolarity was measured using the TearLab osmolarity system (Escondido, CA, USA) by applying 1.0 μl tears collected by micropipette to the TearLab test card or by direct contact between the test card and the temporal tear meniscus. For in vitro analyses, osmolarity of 271.25, 300, 347.5, and 395 mOsm/L solutions were measured at various volumes (0.2, 0.5, 1.0, 2.0, and 5.0 μl) with a TearLab osmometer. Tear osmolarity measured by direct contact was higher than that measured by micropipette (13.7 ± 10.5 mOsm/L, p < 0.001). The difference of osmolarities was higher in the non-SS ADDE, SS ADDE, and CCh than in the NC and EDE (p < 0.001 for all). Osmolarity was negatively correlated with Schirmer score and TMH (r = - 0.346, p < 0.001; r = - 0.447, p < 0.001, respectively). The smaller the sample volume, the higher the measured osmolarity in the in vitro analysis at 300 and 347.5 mOsm/L (r = - 0.659, p < 0.01; r = - 0.579, p < 0.05, respectively). The TearLab osmometer tended to report higher tear osmolarity inversely proportional to sample volumes, possibly due to the evaporation effect. Therefore, care should be taken when interpreting tear osmolarity in patients with low tear volume or CCh.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.